ArticlePharmacoEconomics - open2020

Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection.

Rachael Batteson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.